Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Operating Expenses | 100 | 80 | 51 | 185 |
| Operating Income | -100 | -80 | -51 | -185 |
| Other Income | 6 | 5 | 1 | 0 |
| Pre-tax Income | -94 | -74 | -50 | -185 |
| Net Income Continuous | -94 | -74 | -50 | -185 |
| Net Income | $-94 | $-74 | $-50 | $-185 |
| EPS Basic Total Ops | -0.04 | -0.03 | -0.02 | -0.11 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.02 | -0.11 |
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.02 | -0.11 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.02 | -0.11 |
| EBITDA(a) | $-100 | $-80 | $-51 | $-185 |